ACE2 and COVID-19: Similar to SARS-CoV, the SARS-CoV-2 receptor-binding domain recognizes a host receptor with great similarity to the human angiotensin-converting enzyme 2 (ACE2), and the affinity of this recognition was shown to determine susceptibility towards SARS-CoV-2 infection [23,24,25,26].